NOEMI
PUIG MORON
Investigadora desde 2015
José Juan
Pérez Morán
Publicaciones en las que colabora con José Juan Pérez Morán (11)
2023
-
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 16, pp. 3019-3031
-
Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia
Leukemia, Vol. 37, Núm. 2, pp. 388-395
2022
-
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 40, Núm. 27, pp. 3151-3161
2021
2020
-
Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma
Blood, Vol. 135, Núm. 26, pp. 2375-2387
2019
-
Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis
Leukemia, Vol. 33, Núm. 5, pp. 1256-1267
2017
-
DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma
Journal of Hematology and Oncology, Vol. 10, Núm. 1
2016
-
Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma
Cytometry Part B - Clinical Cytometry, Vol. 90, Núm. 1, pp. 61-72
-
Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases
Cytometry Part B - Clinical Cytometry, Vol. 90, Núm. 1, pp. 91-100
2015
-
The cellular origin and malignant transformation of Waldenström macroglobulinemia
Blood, Vol. 125, Núm. 15, pp. 2370-2380
-
The prognostic value of multiparameter flow cytometry minimal residual disease assessment in relapsed multiple myeloma
Haematologica, Vol. 100, Núm. 2, pp. e53-e55